Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonulcer dyspepsia.

Nimish Vakil1

  • 1Division of Gastroenterology, Department of Medicine, University of Wisconsin Medical School, Aurora Sinai Medical Center, Milwaukee, WI 53233, USA. nvakil@wisc.edu

Current Gastroenterology Reports
|November 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Treatment of <i>Helicobacter pylori</i> Infection Pose a Risk to Patients With GERD?

Gastroenterology & hepatology·2026
Same author

Gastric cancer secondary prevention in dyspeptic patients.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026
Same author

Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.

Journal of clinical pharmacology·2025
Same author

Peptic Ulcer Disease: A Review.

JAMA·2024
Same author

Endoscopic Diagnosis, Grading, and Treatment of Bleeding Peptic Ulcer Disease.

Gastrointestinal endoscopy clinics of North America·2024
Same author

Developments in Gastroesophageal Reflux Disease over the Last 40 Years.

Digestive diseases (Basel, Switzerland)·2023

Nonulcer dyspepsia treatment remains challenging due to its varied nature. Current therapies offer limited efficacy, necessitating novel approaches for this prevalent condition.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Clinical Therapeutics

Background:

  • Nonulcer dyspepsia is a common clinical diagnosis.
  • It represents a heterogeneous group of gastrointestinal disorders.
  • Current treatment strategies for nonulcer dyspepsia are largely unsatisfactory.

Purpose of the Study:

  • To review the current therapeutic landscape for nonulcer dyspepsia.
  • To evaluate the efficacy and limitations of existing treatments.
  • To highlight the need for new treatment modalities.

Main Methods:

  • Literature review of clinical trials and therapeutic guidelines.
  • Analysis of treatment outcomes for Helicobacter pylori eradication, antisecretory agents, prokinetic agents, and emerging therapies.

Related Experiment Videos

  • Assessment of evidence for 5-HT(4) agonists, 5-HT(3) antagonists, and hypnotherapy.

    • Main Results:

    • Helicobacter pylori eradication shows limited benefit.
    • Antisecretory therapy provides modest symptom relief.
    • Prokinetic agents may offer benefits, but trial bias is a concern.
    • Partial 5-HT(4) agonists show promise for gastric motility.
    • Data on 5-HT(3) antagonists and hypnotherapy are scarce.

    Conclusions:

    • The management of nonulcer dyspepsia requires further investigation.
    • Novel therapeutic strategies are essential for this chronic condition.
    • Addressing the heterogeneity of nonulcer dyspepsia is key to effective treatment.